Xu, Yong <br/><br/>
Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection.  [electronic resource] 

 -  PloS one  2013 
 - e76652 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0076652  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anesthetics, Inhalation--administration & dosage<br/>Animals<br/>Apoptosis--drug effects<br/>Cardiotonic Agents--administration & dosage<br/>Coronary Artery Disease--etiology<br/>Diet<br/>Glycogen Synthase Kinase 3--antagonists & inhibitors<br/>Glycogen Synthase Kinase 3 beta<br/>Heart Ventricles--drug effects<br/>Hemodynamics--drug effects<br/>Hypercholesterolemia--complications<br/>Ischemic Postconditioning<br/>Male<br/>Methyl Ethers--administration & dosage<br/>Mitogen-Activated Protein Kinase 1--metabolism<br/>Mitogen-Activated Protein Kinase 3--metabolism<br/>Muscular Dystrophies, Limb-Girdle--metabolism<br/>Myocardial Reperfusion Injury--drug therapy<br/>Myocardium--metabolism<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Rats<br/>Sevoflurane